5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Rainbow Children's Medicare Ltd.

•
rainbowhospitals.inBSE: 543524NSE: RAINBOW
Market Cap₹ 14,836 Cr.
Current Price
High / Low₹ 1,610 / 1,084
Stock P/E52.0
Book Value₹ 168
Price to Book7.19
Dividend Yield0.24 %
ROCE28.2 %
ROE18.1 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 48.1% CAGR over last 5 years
  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 29.6%
  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 21.2% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.53x)

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Stock is trading at 7.2x its book value
  • Operating margins have contracted to 32.2% from 36.7%
  • Growth is decelerating - 3Y profit CAGR (9.9%) trails the 5Y trend (48.1%)
  • Expensive relative to growth - PEG of 5.3
  • Though reporting repeated profits, the company pays out little dividend (12.8%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250
S.No.Name
1.APOLLOHOSP8875.0061.07127608.880.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1039.0069.41101126.940.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS733.10108.0796430.300.002434.30—30906.30—13.9323.83
4.FORTIS901.8064.9768082.130.11272.802.262545.0317.4614.0721.28
5.ASTERDM766.70209.7166831.130.0029.28-68.701310.6821.6011.2619.53
6.MEDANTA1459.5570.5639243.180.03157.25-1.091304.0526.5019.3821.99
7.NH1909.1047.8039014.520.24207.275.372683.6378.0516.2017.43
8.KIMS772.75158.8632456.000.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1916.7059.3732171.581.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE505.05107.9216011.410.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1498.5082.3215434.210.1353.1037.61230.9822.8330.2842.66
12.RAINBOW1460.7551.9914836.350.2462.5416.23469.9933.1728.2528.65
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
287333336341330417398370353445445460470
199215218236236270264255249296298315399
Operating Profit881181181069414713411510414914714571
OPM %30.54%35.34%35.15%30.94%28.38%35.23%33.75%31.00%29.36%33.47%33.00%31.46%15.16%
889131211131520811413
Interest15131417181818181819202021
Depreciation25272832343535343436404142
Profit before Tax5685856953105947771102988784
Tax %25.40%25.91%26.18%26.18%25.55%25.01%26.92%26.53%24.62%26.13%24.36%9.87%25.51%
Net Profit0000407969575476747863
4.046.206.125.023.897.776.765.555.277.417.147.595.97

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
3214025437196509741,1741,2971,5161,7031,820
2663324315194856667748651,0221,1551,308
Operating Profit5570112201165308400432494548512
OPM %17.10%17.30%20.61%27.90%25.40%31.61%34.05%33.34%32.60%32.20%28.12%
111081010193137514235
Interest3464846565863778281
Depreciation22283769738390112138151159
Profit before Tax4147789356187282295330358371
Tax %24.00%22.45%25.37%40.72%28.96%25.98%24.63%25.96%25.99%21.41%21.72%
Net Profit3136585540139212218244282290
EPS6.787.8412.535.924.1714.4520.8921.3823.9727.41—
Dividend Payout %7.51%12.31%7.62%15.78%0.00%13.60%14.44%14.03%12.52%12.77%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
21%
3 Years:
13%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
47%
3 Years:
10%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
12%
1 Year:
-3%

RETURN ON EQUITY

10 Years:
17%
5 Years:
22%
3 Years:
18%
Last Year:
18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 21

₹ 0.35

Rs.3.5000 per share(35%)Final Dividend

2025

Jun 27

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2024

Jul 23

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2023

Jun 22

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2022

Sep 7

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
94444444494102102102102
Minority Interest00042356716
3083073613503914989581,1481,3651,543
151250472505559560748742909
Trade Payables202435585464798184101
466070170826641594856
Total Liabilities3994485591,0981,0781,2841,7452,1442,3472,725
1742963447027728589311,2531,3981,756
Capital Work in Progress712234329521142876
60310182258308571404
76716101519242842
00000007077103
Cash & Bank883675979518547102034
11798107231154199669466226310
Total Assets3994485591,0981,0781,2841,7452,1442,3472,725

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
4361105191169286410321396420
Cash from Investing-33-42-117-117-83-175-465-226-268-259
Cash from Financing-1-728-52-61-44143-102-118-147
1-222-147-71014

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
49.8849.8549.8549.8549.8549.8549.8449.8449.84
24.7825.1125.1223.6923.6021.8519.2417.2416.03
13.8113.8413.8715.3115.4417.4619.4921.1222.56
Government0.000.000.000.000.000.000.000.000.00
11.5411.2011.1611.1411.1110.8411.4411.7911.57

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-11 - Rainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet of Analyst/Institutional Investors Group Meetings.

2026-08-31
Resignation of Director/KMP/SMP

2026-08-31 - Rainbow Childrens Medicare Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-31
Resignation

2026-08-31 - RAINBOW: Rainbow Children's Medicare Limited has informed the Exchange regarding Resignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05, 2026.

2026-08-25
Resignation of Director/KMP/SMP

2026-08-25 - Rainbow Childrens Medicare Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-25
Resignation

2026-08-25 - Rainbow Childrens Medicare Limited has informed the Exchange regarding Resignation of Mr Vikas Maheshwari as Chief Financial Officer of the company w.e.f. August 31, 2026.

2026-08-14
General Updates

2026-08-14 - Rainbow Childrens Medicare Limited has informed the Exchange about Update on Acquisition.

2026-08-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-04 - Rainbow Childrens Medicare Limited has informed the Exchange about Transcript

2026-07-31
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-31 - Rainbow Childrens Medicare Limited has informed the Exchange about Link of Recording

2026-07-31
Copy of Newspaper Publication

2026-07-31 - Rainbow Childrens Medicare Limited has informed the Exchange about Copy of Newspaper Publication of financial results for quarter ended June 30, 2026

News

Recent coverage and analyst commentary for RAINBOW

Loading news…

🤖

AI Stock Analyst

Rainbow Children's Medicare Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login